Biotech News

Iridex Reports Third Quarter 2026 Financial Results

IRIDEX (IRIX)IRIDEXEarnings

SAN JOSE, Calif., Nov. 17, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader in innovative laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today reported financial results for the third quarter ended

Related news

IRIDEX

Ophthalmic Laser Technology Company Iridex develops, manufactures, and markets laser-based medical systems, delivery devices, and accessories for ophthalmology. Its products are used by eye-care specialists to treat glaucoma, diabetic macular edema, and other retinal diseases. MicroPulse Technology The company's proprietary MicroPulse...

Recent company news

Stock data

Close
0.47 USD
Market cap
20.37M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States